当前位置: X-MOL 学术J. Antimicrob. Chemother. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
Journal of Antimicrobial Chemotherapy ( IF 3.9 ) Pub Date : 2020-07-09 , DOI: 10.1093/jac/dkaa273
R Palich 1 , M Wirden 2 , G Peytavin 3 , M-P Lê 3 , S Seang 1 , B Abdi 2 , L Schneider 1 , R Tubiana 1 , M-A Valantin 1 , O Paccoud 1 , C Soulié 2 , V Calvez 2 , C Katlama 1 , A-G Marcelin 2
Affiliation  

To assess genotypic sensitivity scores (GSSs), plasma antiretroviral concentrations (PACs) and immunovirological outcomes at Week 96 (W96) in patients with persistent low-level viraemia (LLV).

中文翻译:

经历过抗逆转录病毒治疗的患者持续的低水平病毒血症与病毒耐药性或药物浓度不足无关。

评估持续性低水平病毒血症(LLV)患者在第96周(W96)的基因型敏感性评分(GSS),血浆抗逆转录病毒浓度(PACs)和免疫病毒学结果。
更新日期:2020-07-09
down
wechat
bug